Share Price and Basic Stock Data
Last Updated: December 18, 2025, 3:47 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
HB Portfolio Ltd operates within the finance and investments sector, a space that has seen a mix of fortunes in recent years. The company reported sales of ₹23.06 Cr for the fiscal year ending March 2023, which marked an increase from ₹18.57 Cr in the previous year. However, revenue volatility is evident in its quarterly results, with fluctuations ranging from ₹2.49 Cr in March 2023 to a notable surge to ₹54.77 Cr in March 2024. This spike hints at potential seasonal or strategic factors driving revenue, but the subsequent decline to ₹28.26 Cr in March 2025 raises questions about sustainability. The erratic sales pattern could be attributed to market conditions or internal operational challenges, necessitating a closer examination of the company’s strategic direction.
Profitability and Efficiency Metrics
Profitability metrics for HB Portfolio reveal a mixed performance. The reported net profit of ₹3.06 Cr for FY 2023 represents a recovery from a loss of ₹2.27 Cr in the preceding quarter, showcasing some operational resilience. However, the company’s return on equity (ROE) stands at a mere 0.02%, indicating a struggle to generate returns for shareholders. Operating margins have shown significant fluctuations as well, with a high of 55.09% in June 2024, but the overall trend appears to be inconsistent, with operating profit margins (OPM) dipping to -68.67% in March 2023. This volatility can be a red flag for investors, reflecting either operational inefficiencies or external market pressures that could impact future profitability.
Balance Sheet Strength and Financial Ratios
Examining the balance sheet, HB Portfolio appears to be relatively conservative with borrowings reported at just ₹0.68 Cr, which is quite low compared to its reserves of ₹269.11 Cr. This positions the company comfortably in terms of liquidity, reflected in a current ratio of 37.73, suggesting that it can easily cover short-term obligations. However, the price-to-book value ratio of 0.34x indicates that the stock may be undervalued, or it could also suggest that the market lacks confidence in the company’s growth prospects. The interest coverage ratio of 9.85x is another positive sign, indicating the company can comfortably meet its interest obligations. Yet, the declining trend in profitability metrics raises concerns about how long this balance sheet strength can be sustained if revenue growth does not stabilize.
Shareholding Pattern and Investor Confidence
The shareholding structure of HB Portfolio reveals a significant promoter holding of 61.45%, which reflects strong internal confidence. However, the presence of institutional investors is minimal, with domestic institutional investors (DIIs) holding just 0.02%. This could indicate a lack of broader market confidence or interest from larger financial players, which may weigh on the stock’s perception. The total number of shareholders has also seen a decline, from 65,205 in December 2022 to 62,787 by September 2025. This shrinking investor base can be seen as a warning sign, suggesting that retail investors may be losing faith in the company’s prospects amidst fluctuating performance metrics.
Outlook, Risks, and Final Insight
Looking ahead, HB Portfolio faces a mixed bag of opportunities and challenges. While its strong liquidity position and minimal debt offer a buffer against economic downturns, the volatility in revenue and profitability metrics raises significant concerns. Investors should be wary of the company’s ability to maintain growth momentum, especially given the fluctuating sales figures and inconsistent profit margins. Additionally, the lack of institutional backing may limit the stock’s upside potential. For retail investors, this could translate into a cautious approach; monitoring the company’s quarterly performance closely will be essential. Overall, while there are strengths in the balance sheet and a solid promoter backing, the risks associated with profitability and market confidence cannot be overlooked.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Shares & Stockbrokers Ltd | 11.9 Cr. | 40.5 | 67.7/36.4 | 47.5 | 44.4 | 0.00 % | 3.32 % | 1.74 % | 10.0 |
| Monarch Networth Capital Ltd | 2,365 Cr. | 298 | 484/280 | 15.2 | 111 | 0.33 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 32.4 Cr. | 0.46 | 2.06/0.45 | 4.47 | 0.03 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 5.44 Cr. | 11.0 | 12.6/8.25 | 9.25 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 20.8 Cr. | 40.6 | 72.0/40.6 | 19.9 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Industry Average | 7,214.44 Cr | 1,373.07 | 82.42 | 3,844.37 | 0.36% | 21.70% | 14.20% | 7.22 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.49 | 3.84 | 10.69 | 2.49 | 4.85 | 5.88 | 5.98 | 37.32 | 8.75 | 5.06 | 9.73 | 4.30 | 7.70 |
| Expenses | 2.98 | 2.48 | 8.90 | 4.20 | 3.26 | 3.06 | 3.18 | 36.61 | 3.93 | 4.81 | 10.29 | 6.16 | 4.09 |
| Operating Profit | 2.51 | 1.36 | 1.79 | -1.71 | 1.59 | 2.82 | 2.80 | 0.71 | 4.82 | 0.25 | -0.56 | -1.86 | 3.61 |
| OPM % | 45.72% | 35.42% | 16.74% | -68.67% | 32.78% | 47.96% | 46.82% | 1.90% | 55.09% | 4.94% | -5.76% | -43.26% | 46.88% |
| Other Income | 0.01 | 0.01 | 0.01 | -0.01 | 0.21 | -0.00 | 0.08 | 0.72 | 0.11 | 0.14 | 0.09 | 0.11 | 0.05 |
| Interest | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.10 | 0.04 | 0.04 | 0.21 | 0.02 | 0.02 |
| Depreciation | 0.09 | 0.09 | 0.09 | 0.09 | 0.11 | 0.11 | 0.09 | 0.47 | 0.17 | 0.17 | 0.18 | 0.30 | 0.21 |
| Profit before tax | 2.41 | 1.26 | 1.69 | -1.82 | 1.67 | 2.69 | 2.77 | 0.86 | 4.72 | 0.18 | -0.86 | -2.07 | 3.43 |
| Tax % | 8.30% | -9.52% | 2.96% | 26.37% | 33.53% | 25.28% | 42.96% | 43.02% | 30.51% | 216.67% | 19.77% | -12.56% | 37.90% |
| Net Profit | 2.23 | 1.45 | 1.65 | -2.27 | 1.00 | 2.51 | 2.02 | 1.52 | 3.48 | 0.40 | -0.86 | -3.06 | 2.20 |
| EPS in Rs | 2.06 | 1.35 | 1.53 | -2.11 | 0.92 | 2.33 | 1.88 | 1.41 | 3.22 | 0.37 | -0.80 | -2.84 | 2.03 |
Last Updated: August 19, 2025, 5:15 pm
Below is a detailed analysis of the quarterly data for HB Portfolio Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 7.70 Cr.. The value appears strong and on an upward trend. It has increased from 4.30 Cr. (Mar 2025) to 7.70 Cr., marking an increase of 3.40 Cr..
- For Expenses, as of Jun 2025, the value is 4.09 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 6.16 Cr. (Mar 2025) to 4.09 Cr., marking a decrease of 2.07 Cr..
- For Operating Profit, as of Jun 2025, the value is 3.61 Cr.. The value appears strong and on an upward trend. It has increased from -1.86 Cr. (Mar 2025) to 3.61 Cr., marking an increase of 5.47 Cr..
- For OPM %, as of Jun 2025, the value is 46.88%. The value appears strong and on an upward trend. It has increased from -43.26% (Mar 2025) to 46.88%, marking an increase of 90.14%.
- For Other Income, as of Jun 2025, the value is 0.05 Cr.. The value appears to be declining and may need further review. It has decreased from 0.11 Cr. (Mar 2025) to 0.05 Cr., marking a decrease of 0.06 Cr..
- For Interest, as of Jun 2025, the value is 0.02 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.02 Cr..
- For Depreciation, as of Jun 2025, the value is 0.21 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.30 Cr. (Mar 2025) to 0.21 Cr., marking a decrease of 0.09 Cr..
- For Profit before tax, as of Jun 2025, the value is 3.43 Cr.. The value appears strong and on an upward trend. It has increased from -2.07 Cr. (Mar 2025) to 3.43 Cr., marking an increase of 5.50 Cr..
- For Tax %, as of Jun 2025, the value is 37.90%. The value appears to be increasing, which may not be favorable. It has increased from -12.56% (Mar 2025) to 37.90%, marking an increase of 50.46%.
- For Net Profit, as of Jun 2025, the value is 2.20 Cr.. The value appears strong and on an upward trend. It has increased from -3.06 Cr. (Mar 2025) to 2.20 Cr., marking an increase of 5.26 Cr..
- For EPS in Rs, as of Jun 2025, the value is 2.03. The value appears strong and on an upward trend. It has increased from -2.84 (Mar 2025) to 2.03, marking an increase of 4.87.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:34 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8.38 | 3.04 | 2.24 | 3.31 | 31.52 | 14.10 | 14.61 | 21.47 | 18.57 | 23.06 | 54.77 | 28.26 | 25.66 |
| Expenses | 1.79 | 1.82 | 2.05 | 2.85 | 17.20 | 16.95 | 19.68 | 16.44 | 11.47 | 19.10 | 46.10 | 25.20 | 24.31 |
| Operating Profit | 6.59 | 1.22 | 0.19 | 0.46 | 14.32 | -2.85 | -5.07 | 5.03 | 7.10 | 3.96 | 8.67 | 3.06 | 1.35 |
| OPM % | 78.64% | 40.13% | 8.48% | 13.90% | 45.43% | -20.21% | -34.70% | 23.43% | 38.23% | 17.17% | 15.83% | 10.83% | 5.26% |
| Other Income | 0.14 | 0.06 | 0.01 | 0.01 | 0.27 | 1.04 | 0.10 | -0.01 | -0.01 | 0.04 | 0.26 | 0.03 | 0.30 |
| Interest | 0.22 | 0.39 | 0.11 | 0.04 | 0.05 | 0.05 | 0.04 | 0.02 | 0.05 | 0.09 | 0.17 | 0.31 | 0.27 |
| Depreciation | -0.01 | 0.19 | 0.07 | 0.06 | 0.30 | 0.28 | 0.27 | 0.28 | 0.31 | 0.36 | 0.79 | 0.83 | 0.90 |
| Profit before tax | 6.52 | 0.70 | 0.02 | 0.37 | 14.24 | -2.14 | -5.28 | 4.72 | 6.73 | 3.55 | 7.97 | 1.95 | 0.48 |
| Tax % | 23.16% | 51.43% | 550.00% | 24.32% | 18.61% | -0.93% | 1.52% | 6.78% | 6.69% | 16.90% | 35.26% | 89.74% | |
| Net Profit | 1.34 | -4.31 | 6.46 | 3.16 | 11.66 | -2.74 | -5.31 | 4.52 | 6.46 | 3.06 | 7.02 | -0.04 | -1.64 |
| EPS in Rs | 1.12 | -3.59 | 5.38 | 2.63 | 10.37 | -2.29 | -3.16 | 3.30 | 6.00 | 2.84 | 6.52 | -0.05 | -1.54 |
| Dividend Payout % | 137.35% | -14.23% | 9.50% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | 28.86% | 15.73% | -2,208.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -421.64% | 249.88% | -51.08% | 268.99% | -123.50% | -93.80% | 185.12% | 42.92% | -52.63% | 129.41% | -100.57% |
| Change in YoY Net Profit Growth (%) | 0.00% | 671.53% | -300.97% | 320.07% | -392.49% | 29.70% | 278.92% | -142.20% | -95.55% | 182.04% | -229.98% |
HB Portfolio Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 14% |
| 3 Years: | 15% |
| TTM: | -54% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 15% |
| 3 Years: | % |
| TTM: | -114% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 35% |
| 3 Years: | 30% |
| 1 Year: | -32% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 2% |
| 3 Years: | 1% |
| Last Year: | 0% |
Last Updated: September 5, 2025, 3:41 pm
Balance Sheet
Last Updated: December 4, 2025, 3:02 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12.27 | 12.27 | 12.27 | 12.27 | 11.04 | 11.04 | 11.04 | 11.04 | 11.04 | 11.04 | 11.04 | 11.04 | 11.04 |
| Reserves | 113.48 | 108.45 | 114.18 | 117.35 | 128.08 | 144.27 | 115.19 | 143.43 | 194.18 | 181.14 | 274.83 | 265.48 | 269.11 |
| Borrowings | 4.60 | 3.08 | 2.43 | 2.34 | 2.48 | 0.27 | 0.09 | 0.06 | 1.02 | 0.84 | 1.76 | 1.06 | 0.68 |
| Other Liabilities | 8.83 | 9.57 | 4.95 | 5.47 | 27.87 | 27.04 | 25.04 | 9.06 | 10.34 | 2.77 | 13.97 | 11.54 | 11.61 |
| Total Liabilities | 139.18 | 133.37 | 133.83 | 137.43 | 169.47 | 182.62 | 151.36 | 163.59 | 216.58 | 195.79 | 301.60 | 289.12 | 292.44 |
| Fixed Assets | 0.51 | 0.33 | 0.28 | 0.23 | 2.49 | 0.82 | 0.82 | 0.63 | 1.91 | 1.67 | 2.49 | 1.95 | 204.64 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 75.47 | 72.27 | 78.68 | 85.17 | 86.02 | 121.26 | 81.88 | 101.83 | 139.31 | 127.32 | 246.89 | 232.55 | 50.74 |
| Other Assets | 63.20 | 60.77 | 54.87 | 52.03 | 80.96 | 60.54 | 68.66 | 61.13 | 75.36 | 66.80 | 52.22 | 54.62 | 37.06 |
| Total Assets | 139.18 | 133.37 | 133.83 | 137.43 | 169.47 | 182.62 | 151.36 | 163.59 | 216.58 | 195.79 | 301.60 | 289.12 | 292.44 |
Below is a detailed analysis of the balance sheet data for HB Portfolio Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 11.04 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 11.04 Cr..
- For Reserves, as of Sep 2025, the value is 269.11 Cr.. The value appears strong and on an upward trend. It has increased from 265.48 Cr. (Mar 2025) to 269.11 Cr., marking an increase of 3.63 Cr..
- For Borrowings, as of Sep 2025, the value is 0.68 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 1.06 Cr. (Mar 2025) to 0.68 Cr., marking a decrease of 0.38 Cr..
- For Other Liabilities, as of Sep 2025, the value is 11.61 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11.54 Cr. (Mar 2025) to 11.61 Cr., marking an increase of 0.07 Cr..
- For Total Liabilities, as of Sep 2025, the value is 292.44 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 289.12 Cr. (Mar 2025) to 292.44 Cr., marking an increase of 3.32 Cr..
- For Fixed Assets, as of Sep 2025, the value is 204.64 Cr.. The value appears strong and on an upward trend. It has increased from 1.95 Cr. (Mar 2025) to 204.64 Cr., marking an increase of 202.69 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 50.74 Cr.. The value appears to be declining and may need further review. It has decreased from 232.55 Cr. (Mar 2025) to 50.74 Cr., marking a decrease of 181.81 Cr..
- For Other Assets, as of Sep 2025, the value is 37.06 Cr.. The value appears to be declining and may need further review. It has decreased from 54.62 Cr. (Mar 2025) to 37.06 Cr., marking a decrease of 17.56 Cr..
- For Total Assets, as of Sep 2025, the value is 292.44 Cr.. The value appears strong and on an upward trend. It has increased from 289.12 Cr. (Mar 2025) to 292.44 Cr., marking an increase of 3.32 Cr..
Notably, the Reserves (269.11 Cr.) exceed the Borrowings (0.68 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 1.99 | -1.86 | -2.24 | -1.88 | 11.84 | -3.12 | -5.16 | 4.97 | 6.08 | 3.12 | 6.91 | 2.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 43.12 | 0.00 | 0.00 | 0.00 | 10.89 | 18.12 | 4.75 | 13.26 | 18.08 | 12.03 | 35.65 | 13.69 |
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 43.12 | 0.00 | 0.00 | 0.00 | 10.89 | 18.12 | 4.75 | 13.26 | 18.08 | 12.03 | 35.65 | 13.69 |
| Working Capital Days | 1,802.35 | 4,740.20 | 6,627.03 | 4,053.60 | 651.37 | 267.15 | 239.84 | 158.95 | 147.42 | 126.31 | 210.19 | 342.91 |
| ROCE % | 5.13% | 0.86% | 0.10% | 0.31% | 9.88% | -1.76% | -3.29% | 3.19% | 3.76% | 1.82% | 3.33% | 0.80% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -0.04 | 4.80 | 2.73 | 5.83 | 4.09 |
| Diluted EPS (Rs.) | -0.04 | 4.80 | 2.73 | 5.83 | 4.09 |
| Cash EPS (Rs.) | 0.93 | 5.39 | 2.99 | 5.97 | 4.24 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 250.52 | 259.35 | 174.45 | 186.26 | 140.28 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 250.52 | 259.35 | 174.45 | 186.26 | 140.28 |
| Revenue From Operations / Share (Rs.) | 25.22 | 48.95 | 20.89 | 16.82 | 19.45 |
| PBDIT / Share (Rs.) | 2.81 | 8.09 | 3.60 | 6.41 | 4.54 |
| PBIT / Share (Rs.) | 2.05 | 7.38 | 3.27 | 6.12 | 4.28 |
| PBT / Share (Rs.) | 1.77 | 7.22 | 3.21 | 6.09 | 4.28 |
| Net Profit / Share (Rs.) | 0.18 | 4.68 | 2.67 | 5.68 | 3.99 |
| NP After MI And SOA / Share (Rs.) | -0.04 | 6.36 | 2.77 | 5.85 | 3.21 |
| PBDIT Margin (%) | 11.12 | 16.52 | 17.22 | 38.07 | 23.33 |
| PBIT Margin (%) | 8.14 | 15.06 | 15.65 | 36.39 | 22.01 |
| PBT Margin (%) | 7.01 | 14.75 | 15.38 | 36.22 | 21.97 |
| Net Profit Margin (%) | 0.74 | 9.56 | 12.76 | 33.79 | 20.49 |
| NP After MI And SOA Margin (%) | -0.19 | 12.99 | 13.25 | 34.76 | 16.51 |
| Return on Networth / Equity (%) | -0.01 | 2.45 | 1.59 | 3.14 | 2.29 |
| Return on Capital Employeed (%) | 0.79 | 2.73 | 1.85 | 3.14 | 2.90 |
| Return On Assets (%) | -0.01 | 2.32 | 1.56 | 2.98 | 2.16 |
| Asset Turnover Ratio (%) | 0.09 | 0.21 | 0.11 | 0.01 | 0.04 |
| Current Ratio (X) | 37.73 | 80.61 | 129.49 | 124.98 | 168.33 |
| Quick Ratio (X) | 37.73 | 80.61 | 129.49 | 124.98 | 168.33 |
| Dividend Payout Ratio (NP) (%) | -2034.78 | 15.32 | 28.17 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 138.60 | 13.78 | 25.19 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 2134.78 | 84.68 | 71.83 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | -38.60 | 86.22 | 74.81 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 9.85 | 52.12 | 63.65 | 222.25 | 688.04 |
| Interest Coverage Ratio (Post Tax) (X) | 1.66 | 31.18 | 48.18 | 198.25 | 605.30 |
| Enterprise Value (Cr.) | 89.11 | 57.65 | 30.47 | 23.12 | 16.30 |
| EV / Net Operating Revenue (X) | 3.20 | 1.07 | 1.32 | 1.25 | 0.75 |
| EV / EBITDA (X) | 28.78 | 6.46 | 7.67 | 3.27 | 3.25 |
| MarketCap / Net Operating Revenue (X) | 3.43 | 1.23 | 1.80 | 1.96 | 0.97 |
| Retention Ratios (%) | 2134.78 | 84.67 | 71.82 | 0.00 | 0.00 |
| Price / BV (X) | 0.34 | 0.23 | 0.21 | 0.17 | 0.13 |
| Price / Net Operating Revenue (X) | 3.43 | 1.23 | 1.80 | 1.96 | 0.97 |
| EarningsYield | 0.00 | 0.10 | 0.07 | 0.17 | 0.16 |
After reviewing the key financial ratios for HB Portfolio Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.04. This value is below the healthy minimum of 5. It has decreased from 4.80 (Mar 24) to -0.04, marking a decrease of 4.84.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.04. This value is below the healthy minimum of 5. It has decreased from 4.80 (Mar 24) to -0.04, marking a decrease of 4.84.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.93. This value is below the healthy minimum of 3. It has decreased from 5.39 (Mar 24) to 0.93, marking a decrease of 4.46.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 250.52. It has decreased from 259.35 (Mar 24) to 250.52, marking a decrease of 8.83.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 250.52. It has decreased from 259.35 (Mar 24) to 250.52, marking a decrease of 8.83.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 25.22. It has decreased from 48.95 (Mar 24) to 25.22, marking a decrease of 23.73.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 2.81. This value is within the healthy range. It has decreased from 8.09 (Mar 24) to 2.81, marking a decrease of 5.28.
- For PBIT / Share (Rs.), as of Mar 25, the value is 2.05. This value is within the healthy range. It has decreased from 7.38 (Mar 24) to 2.05, marking a decrease of 5.33.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.77. This value is within the healthy range. It has decreased from 7.22 (Mar 24) to 1.77, marking a decrease of 5.45.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 2. It has decreased from 4.68 (Mar 24) to 0.18, marking a decrease of 4.50.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -0.04. This value is below the healthy minimum of 2. It has decreased from 6.36 (Mar 24) to -0.04, marking a decrease of 6.40.
- For PBDIT Margin (%), as of Mar 25, the value is 11.12. This value is within the healthy range. It has decreased from 16.52 (Mar 24) to 11.12, marking a decrease of 5.40.
- For PBIT Margin (%), as of Mar 25, the value is 8.14. This value is below the healthy minimum of 10. It has decreased from 15.06 (Mar 24) to 8.14, marking a decrease of 6.92.
- For PBT Margin (%), as of Mar 25, the value is 7.01. This value is below the healthy minimum of 10. It has decreased from 14.75 (Mar 24) to 7.01, marking a decrease of 7.74.
- For Net Profit Margin (%), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 5. It has decreased from 9.56 (Mar 24) to 0.74, marking a decrease of 8.82.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -0.19. This value is below the healthy minimum of 8. It has decreased from 12.99 (Mar 24) to -0.19, marking a decrease of 13.18.
- For Return on Networth / Equity (%), as of Mar 25, the value is -0.01. This value is below the healthy minimum of 15. It has decreased from 2.45 (Mar 24) to -0.01, marking a decrease of 2.46.
- For Return on Capital Employeed (%), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 10. It has decreased from 2.73 (Mar 24) to 0.79, marking a decrease of 1.94.
- For Return On Assets (%), as of Mar 25, the value is -0.01. This value is below the healthy minimum of 5. It has decreased from 2.32 (Mar 24) to -0.01, marking a decrease of 2.33.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.09. It has decreased from 0.21 (Mar 24) to 0.09, marking a decrease of 0.12.
- For Current Ratio (X), as of Mar 25, the value is 37.73. This value exceeds the healthy maximum of 3. It has decreased from 80.61 (Mar 24) to 37.73, marking a decrease of 42.88.
- For Quick Ratio (X), as of Mar 25, the value is 37.73. This value exceeds the healthy maximum of 2. It has decreased from 80.61 (Mar 24) to 37.73, marking a decrease of 42.88.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is -2,034.78. This value is below the healthy minimum of 20. It has decreased from 15.32 (Mar 24) to -2,034.78, marking a decrease of 2,050.10.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 138.60. This value exceeds the healthy maximum of 50. It has increased from 13.78 (Mar 24) to 138.60, marking an increase of 124.82.
- For Earning Retention Ratio (%), as of Mar 25, the value is 2,134.78. This value exceeds the healthy maximum of 70. It has increased from 84.68 (Mar 24) to 2,134.78, marking an increase of 2,050.10.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is -38.60. This value is below the healthy minimum of 40. It has decreased from 86.22 (Mar 24) to -38.60, marking a decrease of 124.82.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 9.85. This value is within the healthy range. It has decreased from 52.12 (Mar 24) to 9.85, marking a decrease of 42.27.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.66. This value is below the healthy minimum of 3. It has decreased from 31.18 (Mar 24) to 1.66, marking a decrease of 29.52.
- For Enterprise Value (Cr.), as of Mar 25, the value is 89.11. It has increased from 57.65 (Mar 24) to 89.11, marking an increase of 31.46.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.20. This value exceeds the healthy maximum of 3. It has increased from 1.07 (Mar 24) to 3.20, marking an increase of 2.13.
- For EV / EBITDA (X), as of Mar 25, the value is 28.78. This value exceeds the healthy maximum of 15. It has increased from 6.46 (Mar 24) to 28.78, marking an increase of 22.32.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.43. This value exceeds the healthy maximum of 3. It has increased from 1.23 (Mar 24) to 3.43, marking an increase of 2.20.
- For Retention Ratios (%), as of Mar 25, the value is 2,134.78. This value exceeds the healthy maximum of 70. It has increased from 84.67 (Mar 24) to 2,134.78, marking an increase of 2,050.11.
- For Price / BV (X), as of Mar 25, the value is 0.34. This value is below the healthy minimum of 1. It has increased from 0.23 (Mar 24) to 0.34, marking an increase of 0.11.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.43. This value exceeds the healthy maximum of 3. It has increased from 1.23 (Mar 24) to 3.43, marking an increase of 2.20.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.10 (Mar 24) to 0.00, marking a decrease of 0.10.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in HB Portfolio Ltd:
- Net Profit Margin: 0.74%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.79% (Industry Average ROCE: 21.7%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -0.01% (Industry Average ROE: 14.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.66
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 37.73
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 82.42)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.74%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | Plot No. 31, Gurgaon Haryana 122001 | corporate@hbportfolio.com http://www.hbportfolio.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Lalit Bhasin | Chairman |
| Mr. Anil Goyal | Managing Director |
| Mrs. Anita Jain | Director |
| Mr. Gurjot Singh Narang | Director |
| Mr. Harbans Lal | Director |
FAQ
What is the intrinsic value of HB Portfolio Ltd?
HB Portfolio Ltd's intrinsic value (as of 18 December 2025) is 0.63 which is 99.04% lower the current market price of 65.50, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 70.5 Cr. market cap, FY2025-2026 high/low of 112/60.1, reserves of ₹269.11 Cr, and liabilities of 292.44 Cr.
What is the Market Cap of HB Portfolio Ltd?
The Market Cap of HB Portfolio Ltd is 70.5 Cr..
What is the current Stock Price of HB Portfolio Ltd as on 18 December 2025?
The current stock price of HB Portfolio Ltd as on 18 December 2025 is 65.5.
What is the High / Low of HB Portfolio Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of HB Portfolio Ltd stocks is 112/60.1.
What is the Stock P/E of HB Portfolio Ltd?
The Stock P/E of HB Portfolio Ltd is .
What is the Book Value of HB Portfolio Ltd?
The Book Value of HB Portfolio Ltd is 260.
What is the Dividend Yield of HB Portfolio Ltd?
The Dividend Yield of HB Portfolio Ltd is 1.54 %.
What is the ROCE of HB Portfolio Ltd?
The ROCE of HB Portfolio Ltd is 0.80 %.
What is the ROE of HB Portfolio Ltd?
The ROE of HB Portfolio Ltd is 0.02 %.
What is the Face Value of HB Portfolio Ltd?
The Face Value of HB Portfolio Ltd is 10.0.